The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Cynthia Kear, MDiv, CHCP; Tom McKeithen, BS, MBA; & Sheila Robertson, MPH, CHCP
Substance Abuse Vol. 38, Iss. 2, 2017
“This article summarizes and interprets the results of a 2015 survey conducted by the CO*RE collaborative. We surveyed clinicians who participated in a CO*RE ER/LA Opioid REMS continuing education program in order to better understand their roles and preferences and provide context for the FDA’s efforts to address the opioid public health crisis. Our results reveal that respondents are comfortable sharing their DEA licensing information, mostly favor a test-based option for CE/CME, and that opioid management responsibilities are distributed among healthcare team members (including non-prescribers) who play critical roles in reducing adverse patient outcomes. These findings could have implications for planning future opioid REMS curriculum and for REMS program goal setting by the FDA.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!